Company News For Nov 1, 2017

PFE UA

  • Shares of Pfizer Inc. (PFE - Free Report) fell 0.3% after posting third quarter 2017 revenues of $13,168 million, below the Zacks Consensus Estimate of $13,169 million
  • Shares of Under Armour, Inc. (UA - Free Report) plummeted almost 22% after posting third quarter 2017 earnings of $0.22 a share, lower than $0.29 a share in the year ago quarter
  • Shares of Aetna Inc. dipped 0.7% after posting third quarter 2017 revenues of $14,948 million, below the Zacks Consensus Estimate of $15,108 million
  • Shares of Acorda Therapeutics, Inc. declined 2.7% after posting third quarter 2017 revenues of $141 million, below the Zacks Consensus Estimate of $151 million

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>